% Expired Patents = 16.7

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 18

Loading Chart...

7 inventors (with patents filed for the assignee):

John Edward Davies (6 out of 15 patents)

Dolores Baksh (4 out of 7 patents)

Rahul Sarugaser (4 out of 6 patents)

4. Morris Hosseini (4 out of 4 patents)

5. Antony D S Lickorish (4 out of 4 patents)

6. Jane Elizabeth Ennis (2 out of 2 patents)

7. Jeffrey Donald Turner (2 out of 2 patents)

6 patents: Sort by Forward Citations

1. 9611456 - Progenitor cells from wharton'S jelly of human umbilical cord (2017-04-04),

2. 9567564 - Progenitor cells from Wharton's jelly of human umbilical cord (2017-02-14),

3. 9498544 - Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents (2016-11-22),

4. 9005599 - Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents (2015-04-14),

5. 8481311 - Progenitor cells from wharton's jelly of human umbilical cord (2013-07-09),

6. 7547546 - Progenitor cells from wharton's jelly of human umbilical cord (2009-06-16),

Company Overview

Tissue Regeneration Therapeutics Inc. is a leading biotechnology company specializing in the development of advanced regenerative therapies for tissue repair and regeneration. With a focus on cutting-edge research and innovative technology, TRT is dedicated to improving patient outcomes and revolutionizing the field of regenerative medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#240 in Toronto

#2,420 in Canada

Toronto, Canada

Tissue Regeneration Therapeutics Inc.

Forward Citations = 18

7 inventors:

John Edward Davies (6 out of 15 patents)

Dolores Baksh (4 out of 7 patents)

Rahul Sarugaser (4 out of 6 patents)

4. Morris Hosseini (4 out of 4 patents)

5. Antony D S Lickorish (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tissue Regeneration Therapeutics Inc.. Retrieved from https://idiyas.com/company/tissue-regeneration-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]